In chronic myelogenous leukemia (CML), ABeLson 1 (ABL1) kinase is constitutively overactivated as a consequence of chromosomal translocation with the breakpoint cluster region, and the induced abnormal cellular environment triggers malignant cell growth, initiating cancers [1]. This evidence concerns the gene ABL1 and cancer.